Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 45 studies | 68% ± 22% | |
pericyte | 30 studies | 46% ± 25% | |
smooth muscle cell | 27 studies | 45% ± 26% | |
connective tissue cell | 17 studies | 71% ± 25% | |
myofibroblast cell | 15 studies | 67% ± 24% | |
endothelial cell | 12 studies | 24% ± 6% | |
mesothelial cell | 12 studies | 66% ± 27% | |
adipocyte | 9 studies | 42% ± 23% | |
macrophage | 5 studies | 32% ± 22% | |
adventitial cell | 5 studies | 62% ± 5% | |
hepatic stellate cell | 3 studies | 37% ± 12% | |
glial cell | 3 studies | 21% ± 6% | |
epithelial cell | 3 studies | 53% ± 26% | |
myeloid cell | 3 studies | 33% ± 15% | |
B cell | 3 studies | 28% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 93% | 50382.25 | 427 / 459 | 94% | 2576.28 | 1046 / 1118 |
lung | 90% | 54803.78 | 523 / 578 | 86% | 1307.00 | 992 / 1155 |
intestine | 98% | 63018.64 | 951 / 966 | 77% | 1027.43 | 407 / 527 |
bladder | 100% | 79149.76 | 21 / 21 | 69% | 963.43 | 350 / 504 |
stomach | 82% | 33600.11 | 295 / 359 | 80% | 1098.38 | 229 / 286 |
esophagus | 82% | 28544.80 | 1185 / 1445 | 76% | 1100.68 | 139 / 183 |
uterus | 99% | 108148.61 | 169 / 170 | 56% | 1181.64 | 258 / 459 |
ovary | 99% | 43091.21 | 178 / 180 | 54% | 671.53 | 231 / 430 |
skin | 80% | 101227.55 | 1442 / 1809 | 56% | 554.74 | 264 / 472 |
prostate | 90% | 30328.21 | 221 / 245 | 31% | 151.98 | 154 / 502 |
pancreas | 15% | 4715.77 | 49 / 328 | 92% | 2644.37 | 164 / 178 |
thymus | 77% | 21403.00 | 503 / 653 | 24% | 215.20 | 145 / 605 |
blood vessel | 99% | 91048.30 | 1328 / 1335 | 0% | 0 | 0 / 0 |
adipose | 98% | 71289.03 | 1180 / 1204 | 0% | 0 | 0 / 0 |
spleen | 76% | 17127.71 | 184 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 60% | 12013.57 | 154 / 258 | 15% | 144.05 | 35 / 230 |
kidney | 40% | 9733.10 | 36 / 89 | 30% | 240.97 | 270 / 901 |
heart | 70% | 32284.25 | 600 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 58% | 881.36 | 26 / 45 |
lymph node | 0% | 0 | 0 / 0 | 41% | 377.67 | 12 / 29 |
liver | 16% | 3476.89 | 37 / 226 | 20% | 147.12 | 83 / 406 |
muscle | 10% | 2252.03 | 81 / 803 | 0% | 0 | 0 / 0 |
brain | 0% | 10.15 | 2 / 2642 | 7% | 88.93 | 48 / 705 |
peripheral blood | 0% | 13.50 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030324 | Biological process | lung development |
GO_0018149 | Biological process | peptide cross-linking |
GO_0001701 | Biological process | in utero embryonic development |
GO_0036022 | Biological process | limb joint morphogenesis |
GO_0007507 | Biological process | heart development |
GO_0034097 | Biological process | response to cytokine |
GO_0007160 | Biological process | cell-matrix adhesion |
GO_0009314 | Biological process | response to radiation |
GO_0032905 | Biological process | transforming growth factor beta1 production |
GO_0002062 | Biological process | chondrocyte differentiation |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0050777 | Biological process | negative regulation of immune response |
GO_0035264 | Biological process | multicellular organism growth |
GO_0021819 | Biological process | layer formation in cerebral cortex |
GO_0001764 | Biological process | neuron migration |
GO_0030168 | Biological process | platelet activation |
GO_0042060 | Biological process | wound healing |
GO_0060350 | Biological process | endochondral bone morphogenesis |
GO_0071711 | Biological process | basement membrane organization |
GO_0097435 | Biological process | supramolecular fiber organization |
GO_0007229 | Biological process | integrin-mediated signaling pathway |
GO_0048144 | Biological process | fibroblast proliferation |
GO_0071230 | Biological process | cellular response to amino acid stimulus |
GO_0060414 | Biological process | aorta smooth muscle tissue morphogenesis |
GO_0048565 | Biological process | digestive tract development |
GO_0048251 | Biological process | elastic fiber assembly |
GO_0021987 | Biological process | cerebral cortex development |
GO_0030199 | Biological process | collagen fibril organization |
GO_0001894 | Biological process | tissue homeostasis |
GO_0035025 | Biological process | positive regulation of Rho protein signal transduction |
GO_0043588 | Biological process | skin development |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_1990776 | Biological process | response to angiotensin |
GO_2001223 | Biological process | negative regulation of neuron migration |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005586 | Cellular component | collagen type III trimer |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0030020 | Molecular function | extracellular matrix structural constituent conferring tensile strength |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
GO_0046332 | Molecular function | SMAD binding |
GO_0005178 | Molecular function | integrin binding |
GO_0002020 | Molecular function | protease binding |
GO_0048407 | Molecular function | platelet-derived growth factor binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | COL3A1 |
Protein name | Alpha-1 type III collagen Collagen alpha-1(III) chain Collagen type III alpha 1 chain |
Synonyms | |
Description | FUNCTION: Collagen type III occurs in most soft connective tissues along with type I collagen. Involved in regulation of cortical development. Is the major ligand of ADGRG1 in the developing brain and binding to ADGRG1 inhibits neuronal migration and activates the RhoA pathway by coupling ADGRG1 to GNA13 and possibly GNA12. |
Accessions | H7C435 ENST00000450867.2 V9GZL2 V9GZS3 V9GZG2 ENST00000304636.9 [P02461-1] V9GZM1 P02461 |